Selective Serotonin Reuptake Inhibitors: all 1,366 studies that test it
Page 13 of 14. Open to participants first (105), then studies with results posted, then the rest; newest registration first within each.
- MOTIV Study- Effect of Antidepressive Treatment by Escitalopram in Patients Undergoing Coronary Artery Bypass GraftingCompletedNCT00243477Phase 4
- Escitalopram Combination Comparison Study for Adult Patients With Major Depressive DisorderStatus unknownNCT00239954Phase 3
- Ziprasidone Versus Olanzapine In The Treatment Of Schizophrenia.CompletedNCT00239109Phase 4
- A Study of the Effects of Risperidone and Olanzapine on Blood Glucose (Sugar) in Patients With Schizophrenia or Schizoaffective DisorderCompletedNCT00236379Phase 4
- Medications for the Treatment of Dysthymic Disorder and Double DepressionCompletedNCT00234312Phase 4
- Investigation of a Combination Treatment of Escitalopram and rTMSCompletedNCT00232700Not applicable
- Treatment of Comorbid Depression and Substance Abuse in Young PeopleCompletedNCT00232284Phase 2
- Study Of Indiplon/Placebo With Sertraline In Insomnia Co-Existing With DepressionTerminatedNCT00232167Phase 3
- Efficacy and Safety Study of Escitalopram Augmentation in Treatment Resistant SchizophreniaCompletedNCT00231335Phase 4
- Effect of Paroxetine on COAT-Platelet Production in Normal Volunteers and Patients With Cardiovascular DiseaseCompletedNCT00229528Phase 4
- Study of Medication and Placebo Response in Major DepressionCompletedNCT00229476Phase 4
- Study of Escitalopram Versus Placebo in the Treatment of Depressive Syndrome in Alzheimer's Disease, Vascular Dementia, and Mixed Vascular and Alzheimer's DementiaStatus unknownNCT00229333Phase 4
- A Study of the Effectiveness and Safety of Dapoxetine in the Treatment of Men With Premature EjaculationCompletedNCT00229073Phase 3
- Maintenance Interpersonal Psychotherapy for Sustaining Remission of DepressionCompletedNCT00227981Not applicable
- Cipralex in Treatment of Depressive Symptoms and Chronic Back PainWithdrawnNCT00227292Phase 4
- Alcohol and Gender Effects on Stress Circuit FunctionCompletedNCT00226694Not applicable
- Treatment of Mild and Subthreshold Depressive DisordersStatus unknownNCT00226642Phase 4
- Study of Paxil Use in Menopausal WomenCompletedNCT00225914Phase 4
- Depression: The Search for Treatment-Relevant Phenotypes-Pilot StudyCompletedNCT00222820Phase 4
- A Naturalistic Study of the Efficacy and Safety of Escitalopram in Treatment Resistant DepressionStatus unknownNCT00220480Not applicable
- Effects of Citalopram on Hostility and CHD RiskCompletedNCT00217828Not applicable
- Risperidone Augmentation for PTSDCompletedNCT00215241Phase 2/3
- A Study of the Effectiveness and Safety of Dapoxetine in the Treatment of Men With Premature Ejaculation.CompletedNCT00211107Phase 3
- A Study of the Effectiveness and Safety of Dapoxetine in the Treatment of Men With Premature EjaculationCompletedNCT00211094Phase 3
- A Study of the Effectiveness and Safety of Dapoxetine in the Treatment of Men With Premature EjaculationCompletedNCT00210704Phase 3
- A Study of Withdrawal Effects With Dapoxetine in the Treatment of Premature EjaculationCompletedNCT00210613Phase 3
- Effect of Escitalopram vs. Reboxetine on Gastro-intestinal Sensitivity of Patients With Major Depressive DisorderStatus unknownNCT00209807Phase 4
- Paroxetine for the Treatment of Interferon Related Side Effects for Hepatitis CCompletedNCT00209118Not applicable
- Does Fluoxetine Have an Effect on the CNS CRF Systems in Women Abused in Childhood?CompletedNCT00208897Not applicable
- A Comparison of Two Standard Therapies in the Management of Dementia With AgitationCompletedNCT00208819Phase 4
- Sertraline vs. Placebo for Symptoms Following Traumatic Brain InjuryStatus unknownNCT00208585Not applicable
- Treatment of Citalopram for Anxiety Disorders Following a Traumatic Brain InjuryStatus unknownNCT00208572Not applicable
- A Trial of Inflammatory Markers, Depressive Symptoms, and Heart DiseaseTerminatedNCT00208117Phase 1
- Risperidone vs. Paroxetine for Panic AttacksTerminatedNCT00206765Phase 2
- Janssen - Glucose Regulation/Risp/OlanzCompletedNCT00205738Not applicable
- Pfizer/IVGTT/Ziprasidone/OlanzapineCompletedNCT00205725Not applicable
- Comparison of Combination Olanzapine+Lithium or Chlorpromazine+Lithium in Treatment of First Manic Episode With Psychotic FeaturesCompletedNCT00202293Phase 4
- A Study of Sertraline and Early Alprazolam XR Administration Versus Sertraline Only in Panic Disorder PatientsCompletedNCT00198094Phase 4
- Efficacy of Paroxetine in the Prevention of Depressive Syndrome in Patients With Chronic Hepatitis C Treated by PEG-Interferon Alfa Plus RibavirinCompletedNCT00196664Phase 3
- Study Comparing Venlafaxine vs. Paroxetine in Panic DisorderCompletedNCT00195598Phase 3
- Treatment Choices for Improving Adherence and OutcomeCompletedNCT00194948Not applicable
- Pilot Study Evaluating the Safety and Efficacy of Open-Label OlanzapineTerminatedNCT00194064Phase 3
- Optimal Length of Treatment Continuation With Olanzapine After Remission of Manic or Mixed EpisodeCompletedNCT00191997Phase 4
- A Study on Induced Weight Gain During Atypical Antipsychotic Treatment and Its Management With Psychoeducational ProgrammeCompletedNCT00191828Phase 4
- Efficacy Study of Switching Stabilized Schizophrenic Patients From Conventional to Atypical Antipsychotic TreatmentCompletedNCT00191555Phase 4
- Comparison of LY686017 With a Marketed Drug in the Treatment of Social Anxiety DisorderCompletedNCT00191022Phase 2
- Olanzapine Plus Carbamazepine in the Treatment of Bipolar I ManiaCompletedNCT00190892Phase 4
- Serotonin Transporter Inhibitor Escitalopram in Pulmonary HypertensionCompletedNCT00190333Phase 3
- A Neuroimaging Investigation of Brain Activity in Major Depressive Disorder and Bipolar DisorderCompletedNCT00188942Phase 4
- Effect of the Menstrual Cycle on the Symptoms of Depression and Treatment ResponseCompletedNCT00188396Not applicable
- RCT of Cognitive Therapy, Paroxetine, Combined CT and Paroxetine and PlaceboCompletedNCT00184106Phase 4
- Determining the Safety and Effectiveness of Olanzapine in Children and AdolescentsTerminatedNCT00183612Not applicable
- Long-Term Olanzapine Treatment in Children With AutismCompletedNCT00183404Phase 2/3
- Sertraline in Generalized Social Phobia With Co-Occurring Anxiety and Mood DisordersTerminatedNCT00182533Phase 4
- Olanzapine in the Treatment of Hair Pulling (Trichotillomania)CompletedNCT00182507Phase 4
- Cognition, Functioning and Quality of LifeCompletedNCT00182442Phase 4
- Open-Label Comparative Study of Risperidone Versus Olanzapine Versus Quetiapine for Mania in Children and Adolescents With Bipolar I and Bipolar II DisorderCompletedNCT00182013Phase 4
- Risperidone Versus Olanzapine for Mania in Preschool Children 4 to 6 Years of Age With Bipolar DisorderCompletedNCT00181935Phase 4
- Sertraline vs. Venlafaxine XRCompletedNCT00179283Phase 3
- The Effectiveness of Sertraline in Patients Who Have Had Inadequate Response to EscitalopramCompletedNCT00179257Phase 3
- Paroxetine and Interpersonal Psychotherapy for Maintaining Health and Well-being in Elderly Individuals With DepressionCompletedNCT00178100Phase 4
- Paroxetine in the Treatment of Chronic Primary InsomniaCompletedNCT00178048Phase 4
- Sleep Deprivation Plus Paroxetine for Treating Major Depression in Elderly IndividualsCompletedNCT00178035Phase 4
- Pharmacotherapy in Depression With Panic SpectrumCompletedNCT00177996Phase 4
- Sertraline for Preventing Post-stroke Depression and Improving Rehabilitation OutcomesTerminatedNCT00177424Phase 4
- Interaction Between Fluvoxamine and SildenafilCompletedNCT00175981Phase 1
- Effectiveness of Clozapine Versus Olanzapine for Treatment-resistant SchizophreniaCompletedNCT00169065Phase 4
- Escitalopram as a Treatment for Pain in PolyneuropathyCompletedNCT00162968Phase 4
- Antidepressant Maintenance in Traumatic Brain InjuryStatus unknownNCT00162916Phase 4
- 3-Week Study of Asenapine, Olanzapine and Placebo for Treatment of Bipolar Mania (P07008)CompletedNCT00159744Phase 3
- Quantitative EEG (QEEG) as a Predictor of Treatment Outcome in DepressionCompletedNCT00157547Phase 4
- Escitalopram as a Mood Stabilizer for Bipolar II DisorderCompletedNCT00156325Phase 2
- A Ten-Week Study Evaluating The Effectiveness And Safety Of Zoloft In Children And Adolescents With A Diagnosis Of PTSDTerminatedNCT00150306Phase 3
- Energy Homeostasis Under Treatment With Atypical AntipsychoticsCompletedNCT00148564Phase 4
- The Efficacy of Escitalopram for Negative Symptoms in SchizophreniaCompletedNCT00148447Phase 3
- Prevention of Post Traumatic Stress Disorder by Early TreatmentCompletedNCT00146900Not applicable
- Kahn Study; Investigation Of The Efficacy Of Ziprasidone Versus Olanzapine In The Management Of Recent-Onset Psychosis; A Flexible-Dose, Parallel Group, Double-Blind StudyCompletedNCT00145444Phase 3
- Multicentre Trial to Evaluate the Safety and Efficacy of CP-316,311 in Major Depressive DisorderTerminatedNCT00143091Phase 2
- Fluoxetine to Reduce Cocaine Use in Cocaine and Opioid AddictsCompletedNCT00142779Not applicable
- DECARD: Study of Escitalopram in the Prevention of Depression in Patients With Acute Coronary SyndromeStatus unknownNCT00140257Phase 4
- Study Of Generalized Anxiety DisorderCompletedNCT00135525Phase 2
- Civilian Post-Traumatic Stress Disorder Risperidone Clinical TrialCompletedNCT00133822Phase 1/2
- Prophylaxis of Psychiatric Symptoms During Anti-HCV TreatmentCompletedNCT00133276Phase 2/3
- Treatment of Depression in the ElderlyTerminatedNCT00130455Phase 4
- Study Comparing Olanzapine With Haloperidol for the Relief of Nausea and Vomiting in Patients With Advanced CancerTerminatedNCT00124930Phase 3
- Study of Escitalopram in the Treatment of Specific PhobiaCompletedNCT00121069Phase 2/3
- Seroquel in Bipolar Depression Versus SSRICompletedNCT00119652Phase 3
- Sertraline and Habit Reversal in the Treatment of Patients With TrichotillomaniaCompletedNCT00118014Phase 4
- Escitalopram for the Treatment of Obsessive Compulsive Disorder (OCD)CompletedNCT00116532Phase 4
- Escitalopram for the Treatment of Self-Injurious Skin PickingCompletedNCT00115011Phase 4
- SSRI Administration to Reduce Acute Stress Disorder Symptoms and Prevent Depression and PTSD in Physical Trauma VictimsTerminatedNCT00114374Phase 3
- Fluoxetine as a Quit Smoking AID for Depression ProneCompletedNCT00113737Not applicable
- Olanzapine Treated Adolescents With Schizophrenia or Bipolar I DisorderCompletedNCT00113594Phase 3
- Comparison of Escitalopram Combination in Adult Patients With Major Depressive DisorderCompletedNCT00109044Phase 3
- Study of Escitalopram in Adult Patients With Major Depressive DisorderCompletedNCT00108979Phase 3
- The Effects of Risperidone and Olanzapine on ThinkingCompletedNCT00108368Phase 4
- Determinants in Antidepressant OutcomesWithdrawnNCT00108316Not applicable
- Olanzapine Versus Aripiprazole in the Treatment of Acutely Ill Patients With SchizophreniaCompletedNCT00103571Phase 4
- Efficacy of High Dose Olanzapine for the Treatment of Schizophrenia and Schizoaffective DisorderCompletedNCT00100776Phase 4
- Olanzapine vs. Comparator and Placebo in the Treatment of Patients With Bipolar I DisorderCompletedNCT00094549Phase 4